Alejandro Chavez

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Nature communications

Science advances

Nature protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Joonwon Kim, Alexander F Kratz, Shiye Chen, Jenny Sheng, Hark Kyun Kim, Liudeng Zhang, Brijesh Kumar Singh, Alejandro Chavez
High-throughput tagging of endogenous loci for rapid characterization of protein function. Science advances 10 (18) (2024)
Joonwon Kim, Alexander F Kratz, Shiye Chen, Jenny Sheng, Hark Kyun Kim, Liudeng Zhang, Brijesh Kumar Singh, Alejandro Chavez
High-throughput tagging of endogenous loci for rapid characterization of protein function. Science advances 10 (18) (2024)
Yinkai Duan, Hao Zhou, Xiang Liu, Sho Iketani, Mengmeng Lin, Xiaoyu Zhang, Qucheng Bian, Haofeng Wang, Haoran Sun, Seo Jung Hong, Bruce Culbertson, Hiroshi Mohri, Maria I Luck, Yan Zhu, Xiaoce Liu, Yuchi Lu, Xiu-Na Yang, Kailin Yang, Yosef Sabo, Alejandro Chavez, Stephen P Goff, Zihe Rao, David D Ho, Haitao Yang
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir. Nature (2023)
George D Lampe, Rebeca T King, Tyler S Halpin-Healy, Sanne E Klompe, Marcus I Hogan, Phuc Leo H Vo, Stephen Tang, Alejandro Chavez, Samuel H Sternberg
Targeted DNA integration in human cells without double-strand breaks using CRISPR RNA-guided transposases. bioRxiv : the preprint server for biology (2023)
Sho Iketani, Hiroshi Mohri, Bruce Culbertson, Seo Jung Hong, Yinkai Duan, Maria I Luck, Medini K Annavajhala, Yicheng Guo, Zizhang Sheng, Anne-Catrin Uhlemann, Stephen P Goff, Yosef Sabo, Haitao Yang, Alejandro Chavez, David D Ho
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. Nature (2022)
Hengrui Liu, Sho Iketani, Arie Zask, Nisha Khanizeman, Eva Bednarova, Farhad Forouhar, Brandon Fowler, Seo Jung Hong, Hiroshi Mohri, Manoj S Nair, Yaoxing Huang, Nicholas E S Tay, Sumin Lee, Charles Karan, Samuel J Resnick, Colette Quinn, Wenjing Li, Henry Shion, Xin Xia, Jacob D Daniels, Michelle Bartolo-Cruz, Marcelo Farina, Presha Rajbhandari, Christopher Jurtschenko, Matthew A Lauber, Thomas McDonald, Michael E Stokes, Brett L Hurst, Tomislav Rovis, Alejandro Chavez, David D Ho, Brent R Stockwell
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19. Nature communications 13 (1) (2022)
Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R Stockwell, Alejandro Chavez, David D Ho
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nature communications 12 (1) (2021)
Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R Stockwell, Alejandro Chavez, David D Ho
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nature communications 12 (1) (2021)
Farzaneh Moghadam, Ryan LeGraw, Jeremy J Velazquez, Nan Cher Yeo, Chenxi Xu, Jin Park, Alejandro Chavez, Mo R Ebrahimkhani, Samira Kiani
Synthetic immunomodulation with a CRISPR super-repressor in vivo. Nature cell biology 22 (9) (2020)
Viola Halder, Caroline B M Porter, Alejandro Chavez, Rebecca S Shapiro
Design, execution, and analysis of CRISPR-Cas9-based deletions and genetic interaction networks in the fungal pathogen Candida albicans. Nature protocols 14 (3) (2019)
Nan Cher Yeo, Alejandro Chavez, Alissa Lance-Byrne, Yingleong Chan, David Menn, Denitsa Milanova, Chih-Chung Kuo, Xiaoge Guo, Sumana Sharma, Angela Tung, Ryan J Cecchi, Marcelle Tuttle, Swechchha Pradhan, Elaine T Lim, Noah Davidsohn, Mo R Ebrahimkhani, James J Collins, Nathan E Lewis, Samira Kiani, George M Church
An enhanced CRISPR repressor for targeted mammalian gene regulation. Nature methods 15 (8) (2018)